Formulation of nanoliposome-encapsulated bevacizumab (Avastin): Statistical optimization for enhanced drug encapsulation and properties evaluation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Formulation of nanoliposome-encapsulated bevacizumab (Avastin): Statistical optimization for enhanced drug encapsulation and properties evaluation

Published:2020-11 Issue: Volume:590 Page:119895
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Malakouti-Nejad Maryam,Bardania Hassan,Aliakbari Farhang,Baradaran-Rafii Alireza,Elahi Elahe,Monti Daniela,Morshedi Dina

Funder

National Institute for Genetic Engineering and Biotechnology

Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference89 articles.

1. Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration;Abrishami;Retina,2009

2. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N. Engl. J. Med.,1994

3. Factors affecting the clearance and biodistribution of polymeric nanoparticles;Alexis;Mol. Pharm.,2008

4. Liposome-bound cyclosporine: Retinal toxicity after intravitreal injection;Alghadyan;Int. Ophthalmol.,1988

5. The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson’s Disease;Aliakbari;Nanoscale,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective;BioImpacts;2024-05-19

2. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

3. Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery;Pharmaceuticals;2024-04-16

4. The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity;Science Advances;2024-04-05

5. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3